Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata

키워드

참고문헌 (35)

1. Picardo M, "Vitiligo", Nat Rev Dis Primers, 1, pp.15011~ (2015)
2. Harris JE, "Cellular stress and innate inflammation in organspecific autoimmunity : lessons learned from vitiligo", Immunol Rev, 269, pp.11~25 (2016)
3. Rork JF, "Understanding autoimmunity of vitiligo and alopecia areata", Curr Opin Pediatr, 28, pp.463~469 (2016)
4. Liu M, "Rethinking screening for thyroid autoimmunity in vitiligo", J Am Acad Dermatol, 75, pp.1278~1280 (2016)
5. Mockenhaupt M, "Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes", Int J Mol Med, 12, pp.597~601 (2003)
6. Miniati A, "Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin : relevance to early vitiligo", Clin Exp Dermatol, 39, pp.54~57 (2014)
7. Lee HT, "Serum BLC", CXCL13 concentrations and renal expression of CXCL13, J Rheumatol, pp.2010, 37[DOI]
8. Wutte N, "CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis", Br J Dermatol, 169, pp.723~725 (2013)
9. Rashighi M, "CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo", Sci Transl Med, 6, pp.223~ (2014)[DOI]
10. Wang XX, "Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo", Br J Dermatol, 174, pp.1318~1326 (2016)
11. Speeckaert R, "S100B is a potential disease activity marker in nonsegmental vitiligo", J Invest Dermatol, 137, pp.1445~1453 (2017)
12. Kim JY, "Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo", Br J Dermatol, 176, pp.1558~1568 (2017)
13. Speeckaert R, "Alterations of CXCL12in serum of patients with vitiligo", J Invest Dermatol, 137, pp.1586~1588 (2017)
14. Li S, "Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes", J Allergy Clin Immunol, 140, pp.177~189 (2017)
15. Stinco G, "Serological screening for autoimmune polyendocrine syndromes in patients with vitiligo", J Eur Acad Dermatol Venereol, 26, pp.1041~1042 (2012)
16. Laberge G, "Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo", Pigment Cell Res, 18, pp.300~305 (2005)
17. Vrijman C, "The prevalence of thyroid disease in patients with vitiligo : a systematic review", Br J Dermatol, 167, pp.1224~1235 (2012)
18. Xing L, "Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition", Nat Med, 20, pp.1043~1049 (2014)
19. Taïeb A, "The definition and assessment of vitiligo : a consensus report of the Vitiligo European Task Force", Pigment Cell Res, 20, pp.27~35 (2007)
20. Fröhlich E, "Thyroid autoimmunity : role of antithyroid antibodies in thyroid and extra-thyroidal diseases", Front Immunol, 8, pp.521~ (2017)
21. Maouia A, "Differential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patients", Pigment Cell Melanoma Res, 30, pp.259~261 (2017)
22. Richmond JM, "Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease", J Invest Dermatol, 137, pp.350~358 (2017)
23. Campbell JD, "Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop", FASEB J, 18, pp.329~331 (2004)
24. Lang KS, "HLA-A2 restricted, melanocyte-specific CD8(+)T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA", MART1, 2001, pp.116, 891~897
25. van den Boorn JG, "Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients", J Invest Dermatol, 129, pp.2220~2232 (2009)
26. Nanba T, "Increases of the Th1", Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease, 2009, pp.19, 495~501
27. McElwee KJ, "What causes alopecia areata", Exp Dermatol, 22, pp.609~626 (2013)
28. Gilhar A, "Lymphocytes, neuropeptides, and genes involved in alopecia areata", J Clin Invest, 117, pp.2019~2027 (2007)
29. Gill L, "Comorbid autoimmune diseases in patients with vitiligo : a cross-sectional study", J Am Acad Dermatol, 74, pp.295~302 (2016)
30. Medici M, "Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease", PLoS Genet, 10, pp.e1004123~ (2014)
31. Spritz RA, "Novel vitiligo susceptibility loci on chromosomes 7(AIS2)and 8(AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis", Am J Hum Genet, 74, pp.188~191 (2004)
32. Gey A, "Autoimmune thyroid disease in vitiligo : multivariate analysis indicates intricate pathomechanisms", Br J Dermatol, 168, pp.756~761 (2013)
33. Rotondi M, "Role of chemokines in endocrine autoimmune diseases", Endocr Rev, 28, pp.492~520 (2007)
34. Ferrari SM, "Circulating CXCL10 is increased in nonsegmental vitiligo, in presence or absence of autoimmune thyroiditis", Autoimmun Rev, 16, pp.946~950 (2017)
35. Van Raemdonck K, "CXCR3 ligands in disease and therapy", Cytokine Growth Factor Rev, 26, pp.311~327 (2015)

관련 논문AI추천